Steroid-sensitive nephrotic syndrome in children: Triggers of relapse and evolving hypotheses on pathogenesis

Italian Journal of Pediatrics

Volumn 41, Issue 1, 2015, Pages

  Uwaezuoke, Samuel N ^a,b  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b UNTH Ituku Ozalla   (Nigeria)

Author keywords

Children; Pathogenesis; Relapse; Steroid sensitive nephrotic syndrome

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; STEROID; ZINC; GLUCOCORTICOID;

CHILD; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SENSITIVITY; GLOMERULUS FILTRATION; HUMAN; IMMUNE DYSREGULATION; KIDNEY INJURY; NEPHROTIC SYNDROME; PATHOGENESIS; PODOCYTE; PODOCYTOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; RESPIRATORY TRACT INFECTION; REVIEW; STEROID SENSITIVE NEPHROTIC SYNDROME; URINARY TRACT INFECTION; COMORBIDITY; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; RESPIRATORY TRACT INFECTIONS; URINARY TRACT INFECTIONS;

CHILD; COMORBIDITY; GLUCOCORTICOIDS; HUMANS; NEPHROTIC SYNDROME; PODOCYTES; PREDNISOLONE; PROGNOSIS; RECURRENCE; RESPIRATORY TRACT INFECTIONS; URINARY TRACT INFECTIONS;

EID: 84928138770     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/s13052-015-0123-9     Document Type: Review

References (57)

1. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics. 2000;105:1242-9.
2. Lombel RM, Gipson DS, Hodson EM. Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol. 2013;28:415-26.
3. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629-39.
4. International Study of Kidney Disease in Children. Nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 1978;13:159-65.
5. Churg J, Habib R, White RH. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet. 1970;760:1299-302.
6. Trumpeter RS, Lloyd BW, Hicks J, White RH, Cameron JS. Long-term outcome for children with minimal change nephrotic syndrome. Lancet. 1985;1:368-70.
7. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. Pediatr. 1981;98:561-4.
8. International Study of Kidney Disease in Children. Primary nephrotic syndrome in children. Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int. 1981;20:765-71.
9. Tarshish P, Tobin JN, Bernstein J, Edelmann Jr CM. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1977;8:769-76.
10. International Study of Kidney Disease in Children. Nephrotic syndrome in children: a randomized controlled trial comparing two prednisolone regimens in steroid-responsive patients who relapse early. J Pediatr. 1982;95:239-43.
11. Teeninga N, Kist-van Holthe JE, Nauta J. Extending Prednisolone Treatment Does Not Reduce Relapses in Childhood Nephrotic Syndrome. J Am Soc Nephrol. 2012;24:149-59.
12. Webb NJA. Epidemiology and general management of childhood idiopathic nephrotic syndrome. In: Molony D, Craig J, editors. Evidence-based Nephrology. Oxford, UK: Wiley-Blackwell; 2008.
13. Hall AS, Thorley G, Houtman PN. The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol. 2003;18:1220-3.
14. Moorani KN. Infections are common a cause of relapse in children with Nephrotic syndrome. Pak Paed J. 2011;35:213-9.
15. MacDonald N, Wolfish N, Mclaine P, Phipps P, Rossier E. Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Paediatr. 1986;108:378-82.
16. Takahashi S, Wada N, Murakami H, Funaki S, Inagaki T, Harada K, et al. Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome. Pediatr Nephrol. 2007;22:232-6.
17. Gulati S, Kher V, Gupta P, Arora P, Rai K, Sharma K. Spectrum of infections in Indian children with nephrotic syndrome. Pediatr Nephrol. 1995;9:431-4.
18. Shenguttuvan P, Ravanan K, Prabhu N, Tamilarasi V. Infections encountered in childhood nephrotics in a pediatric renal unit. Indian J Nephrol. 2004;14:85-8.
19. Afroz S, Khan Hossain MA, Roy KD, Ahmed F, ul Qadir M, Hanif M. Urinary Tract Infection (UTI) is associated with higher rate of relapse in children with nephrotic syndrome. DS (Child) H J. 2010;26:82-6.
20. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Inter Suppl. 2002;2:139-274.
21. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13-28.
22. Neuhaus TJ, Shah V, Callard RE, Barratt TM. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood. Nephrol Dial Transplant. 1995;10:1348-52.
23. Bagga A, Vasudev AS, Moudgil A, Srivastava RN. Peripheral blood lymphocyte subsets in idiopathic nephrotic syndrome of childhood. Indian J Med Res. 1996;104:292-5.
24. Mathieson PW. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant. 2003;18:26-9.
25. Mosmann TR, Coffman RL. TH 1 and TH 2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73.
26. Van Den Berg JG, Aten J, Chand MA, Claessen N, Dijkink L, Wijdenes J, et al. Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol. 2000;11:413-22.
27. Brenchley PE. Vascular permeability factors in steroid sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2003;18:21-5.
28. Holt RC, Webb NJ, Ralph S, Davies J, Short CP, Brenchley PE. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome. Kidney Int. 2005;67:122-9.
29. Greenbaum LA, Benndorf R, Smoyer WE. Childhood nephrotic syndromecurrent and future therapies. Nat Rev Nephrol. 2012;8:445-58.
30. Schonenberger E, Ehrich JH, Haller H, Schiffer M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant. 2011;26:18-24.
31. Tullus K, Marks SD. Indications for use and safety of rituximab in childhood renal diseases. Pediatr Nephrol. 2013;28:1001-9.
32. Scott SD. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma". Cancer Pract. 1998;6:195-7.
33. Benz K, Dotsch J, Rascher W, Stachel D. Change of the course of steroiddependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol. 2004;19:794-7.
34. Bruneau S, Dantal J. New insights into the pathophysiology of idiopathic nephrotic syndrome. Clin Immunol. 2007;122:62-74.
35. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V. Rituximab for idiopathic membranous nephropathy. Lancet. 2002;360:923-4.
36. Ruggnenti P, Chiurchiu C, Brusegan V, Abbate M. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol. 2003;14:1851-7.
37. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int. 2008;73:117-25.
38. Gilbert RD, Hulse E, Rigden S. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol. 2006;21:1698-700.
39. Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (MMF)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant. 2008;23:377-80.
40. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Eng J Med. 2006;354:1961-3.
41. Suri M, Tran K, Sharma AP, Filler G, Grimmer J. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int Urol Nephrol. 2008;40:807-10.
42. Hamm LL, Batman V. Edema in the nephrotic syndrome: new aspect of an old enigma. J Am Soc Nephrol. 2003;14:3288-9.
43. Bagga A, Srivatava RN. Nephrotic syndrome. In: Srivastava RN, Bagga A, editors. Pediatric Nephrology. 4th ed. New Delhi: Jaypee; 2005. p. 159-200.
44. Kabuki N, Okugawa T, Hayakawa H, Tomizawa S, Kasahara T, Uchiyama M. Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 1998;12:467-70.
45. Yap HK, Han EJ, Heng CK, Gong WK. Risk factors for steroid dependency in children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2001;16:1049-52.
46. Constantinescu AR, Shah HB, Foote EF, Weiss LS. Predicting first-year relapses in children with nephrotic syndrome. Pediatrics. 2000;105:492-5.
47. Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev. 2008;1:CD002290. doi:10.1002/14651858. CD002290. pub 3.
48. Andersen RF, Thrane N, Noergaard K, Rytter L, Jespersen B, Ritting S. Early age at debut is a predictor of steroid dependent and frequently relapsing nephrotic syndrome. Pediatr Nephrol. 2010;25:1299-304.
49. Letavernier B, Letavernier E, Leroy S, Baudet-Bonneville V, Bensman A, Ulinski T. Prediction of high-degree steroid dependency in Pediatric idiopathic nephrotic syndrome. Pediatr Nephrol. 2008;23:2221-6.
50. Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A. Daily corticosteroids reduce infection-Associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol. 2011;6:163-9.
51. Mattoo TK, Mahmoud MA. Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome. Nephron. 2000;85:343-5.
52. Abeyagunawardena AS, Trompeter RS. Increasing the dose of prednisolone during viral infection reduced the risk of relapse in nephrotic syndrome: a randomized controlled trial. Arch Dis Child. 2008;93:226-8.
53. Webb NJA, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, et al. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomized controlled trial. Trials. 2014;15:147.
54. Arun S, Bhatnagar S, Menon S, Saini S, Hari P, Bagga A. Efficacy of zinc supplements in reducing relapses in steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2009;24:1583-6.
55. Sherali AR, Moorani KN, Chishty SH, Khan SI. Zinc supplement in reduction of relapses in children with steroid-sensitive nephrotic syndrome. J Coll Physicians Surg Pak. 2014;24:110-3.
56. Aggarwal R, Sentz J, Miller M. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-Analysis. Pediatrics. 2007;119:1120-30.
57. Roth DE, Richard SA, Black R. Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-Analysis and meta-regression of randomized trials. Int J Epidemiol. 2010;39:795-808.